Archive: 09/07/2012
New test helps evaluate cancer drug's merit
(HealthDay) -- A new genetic test to help doctors determine if the drug Erbitux would be an effective treatment for certain colorectal cancer patients has been approved by the U.S. Food and Drug Administration.
Jul 9, 2012
Overqualified recent immigrants three times as likely to be injured at work
Men who are recent immigrants and over qualified for their jobs are more than three times as likely to sustain an injury at work as their appropriately qualified peers who have been in the country for some time, suggests ...
Jul 9, 2012
Cutting daily sitting time to under 3 hours might extend life by 2 years
Restricting the amount of time spent seated every day to less than 3 hours might boost the life expectancy of US adults by an extra 2 years, indicates an analysis of published research in the online journal BMJ Open.
Jul 9, 2012
Facebook use leads to depression? No, says Wisconsin study
MADISON- A study of university students is the first evidence to refute the supposed link between depression and the amount of time spent on Facebook and other social-media sites.
Jul 9, 2012
Newer technology to control blood sugar works better than conventional methods
Newer technologies designed to help people with type 1 diabetes monitor their blood sugar levels daily work better than traditional methods and require fewer painful needle sticks, new Johns Hopkins research suggests.
Jul 9, 2012
'Molecular grenade': Drug from Mediterranean weed kills tumor cells in mice
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by ...
Jul 9, 2012